Status:
COMPLETED
Headache Inducing Effect of Cromakalim in Migraine Patients
Lead Sponsor:
Danish Headache Center
Conditions:
Headache, Migraine
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
To investigate the role of KATP channels on the cerebral hemodynamic in migraine patients.
Eligibility Criteria
Inclusion
- Migraine patients of both sexes.
- 18-60 years.
- 50-90 kg.
- Women of childbearing potential must use adequate contraception.
Exclusion
- Headache less than 48 hours before the tests start
- Daily consumption of drugs of any kind other than oral contraceptives
- Pregnant or nursing women.
- Cardiovascular disease of any kind, including cerebrovascular diseases.
Key Trial Info
Start Date :
May 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2017
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT03228355
Start Date
May 24 2017
End Date
November 30 2017
Last Update
June 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish headache center
Copenhagen, Glostrup, Denmark, 2600